ライフサイエンスコーパス: antibody-positive

1 were perinuclear antineutrophil cytoplasmic antibody positive.

2 Five children were antinuclear antibody positive.

3 nitially antibody negative HHCs, none became antibody positive.

4 Of 4713 patients, 652 (13.8%) were HCV antibody positive.

5 ot identified as EHF patients were initially antibody positive.

6 Of 30 healthy blood donors, 20% were antibody positive.

7 7 of 23 serum samples from patients remained antibody positive.

8 607/694 (87%) participants tested were HIV antibody positive.

9 of the 543 bonobo samples from six sites was antibody positive.

10 atient known to be isolated hepatitis B core antibody-positive.

11 her among those who were hepatitis B surface antibody positive (12.5%) as compared to those without d

12 ghing between 13 and 14 g least likely to be antibody positive (12.9%).

13 In the 5777 people who were HCV antibody positive, 2086 (34.4%) reported harmful or haza

14 ce weighing less than 11 g most likely to be antibody positive (26.9%) and juvenile mice weighing bet

15 e 5777 people who inject drugs that were HCV antibody positive, 440 (5.5%) were aware of their status

16 6.9% anti-HBc/anti-HBs (hepatitis B surface antibody) positive, 6.9% isolated anti-HBs positive, and

17 Nineteen mothers were anti-Ro antibody positive, 8 anti-La antibody positive, and 7 ha

18 At baseline, 521 patients (45.4%) were HCV-antibody positive, 85 (7.4%) were hepatitis B surface an

19 We selected 196 antinuclear antibody-positive adult SLE patients (age > or =20 years

20 Twenty antibody-positive adults were orally administered rNV VL

21 We studied HCV antibody-positive adults with HIV in the EuroSIDA study,

22 In contrast, nine cats became antibody positive after FIV vaccination but remained neg

23 erring the risk of anticitrullinated protein antibodies-positive and negative RA.

24 5 samples from eastern chimpanzees, 323 were antibody positive and 92 contained viral RNA.

25 nd congestive heart failure, was antinuclear antibody positive and had muscle biopsy findings "consis

26 hose HLA-identical donor was found to be HCV antibody positive and HCV RNA positive by polymerase cha

27 experimentally FIV-infected cats (n=5) were antibody positive and highly positive in the FIV PCR.

28 here was no survival rate difference between antibody-positive and -negative groups.

29 Antibody-positive and antibody-negative individuals were

30 Serum or plasma samples from HAV antibody-positive and antibody-negative individuals were

31 The prevalence of HCV antibody-positive and chronic HCV infection at accession

32 cted, HIV-negative persons, the frequency of antibody-positive and genotype-concordant couples is 2.8

33 ant clinical difference between anti-U11/U12 antibody-positive and negative cohorts was the prevalenc

34 of vertical HCV infection to children of HCV antibody-positive and RNA-positive women was 5.8% (95% c

35 The most prevalent responses in antibody-positive and type 1 diabetic subjects were to p

36 risk were generated for children born to HCV antibody-positive and viremic women, aged >/=18 months,

37 topenia or thromboembolic events between the antibody-positive and-negative groups.

38 rs were anti-Ro antibody positive, 8 anti-La antibody positive, and 7 had clinical autoimmune disease

39 e living with HIV, 52.3% (42.4-62.1) are HCV-antibody positive, and 9.0% (5.1-13.2) are HBV surface a

40 Fifty-six patients were anti-C1q antibody positive, and Ig subclass analysis indicated a

41 the presence of one or more M. ovipneumoniae antibody-positive animals and the occurrence of current

42 Forty-four specimens from 78 antibody-positive animals had sufficient residual volume

43 was detected in cervical secretions of serum antibody-positive animals, predominantly against MgpB an

44 lly more severe cyclic-citrullinated peptide antibody-positive (anti-CCP+) RA.

45 Patients were divided into antibody-positive (AP) (n = 11) and antibody-negative (A

46 th muscle cell actin and anti-rat macrophage antibody-positive areas were significantly reduced withi

47 Participants who were HCV antibody-positive at enrolment and those with HCV antibo

48 initial workup of 23 patients proven to have antibody-positive autoimmune encephalitis.

49 at come from donors who are hepatitis B core antibody positive because of a fear of transmission of h

50 vidual testing, whereas neither recipient of antibody-positive blood components that were reactive on

51 antibodies, raising the question whether WNV antibody-positive blood components with low levels of WN

52 h follow-up, we examined the effect of HHV-8 antibody-positive blood on transfusion recipients surviv

53 multiple transfusions), recipients of HHV-8 antibody-positive blood stored </=4 days ("short-stored"

54 Transfusion with short-stored HHV-8 antibody-positive blood was associated with an increased

55 ted mortality following transfusion of HHV-8 antibody-positive blood.

56 ents, 471 (43.1%) were transfused with HHV-8 antibody-positive blood.

57 were HCV antibody negative, 34 who were HCV antibody positive but RNA negative, and 112 who were HCV

58 70 (3.5%) of these infants were rubella IgM antibody positive, but none of the infants had features

59 with confirmed CMV infection were CMV-total antibody positive, but only 1 of 3 had CMV-IgM antibody.

60 antigen in acquisition with age: rapid (>80% antibody positive by age 20 years, 5 antigens), moderate

61 Six antibody-positive cancer patients had p53 mutations, whe

62 -DQA1*05-DQB1*02), anti-Jo-1 and anti-PM-Scl antibody-positive cases have differing IIM clinical phen

63 In both experiments, antibody-positive cats were protected from clinical dise

64 35 HIV-1-positive patients with KS, 60% were antibody positive, compared with 27% of 33 HIV-1-positiv

65 nd endogenous human IgG and the neutralizing antibody positive-control (NAb-PC) in the BEAD eluates.

66 al transplant recipients who are hepatitis C antibody positive do not have an increased risk of death

67 e of organs obtained from a hepatitis B core antibody positive donor.

68 ive recipients who received kidneys from HCV antibody positive donors (D-HCV) (n=48); and (3) HCV neg

69 ted in five bone marrow samples from healthy antibody-positive donors.

70 ge of 56 +/- 11 SD) received hearts from HCV-antibody-positive donors.

71 -embedded tissues (FFPE) from donor-specific antibody-positive (DSA+) renal allograft recipients prom

72 Of 101 FIV antibody-positive feline blood specimens submitted for F

73 o measure 16 separate ACPAs in sera from 111 antibody-positive first-degree relatives who were positi

74 found in patients having an AMI and who were antibody positive for dUTPase (ANOVA p=0.008; 369 +/- 18

75 onically infected with HCV, most of whom are antibody positive for HCV E2.

76 RNA positive and 10 nonviremic samples were antibody positive for peptides or NS4AB.

77 spholipid antibodies in lupus patients (4.8% antibody-positive group vs. 16.6% in the antibody-negati

78 nificantly increased in the anti-U11/U12 RNP antibody-positive group.

79 ts, 3.4% (15 of 447) of those who were HSV-1 antibody positive had a subsequent negative result while

80 Sixty patients who were anti-topo I antibody positive had diffuse cutaneous SSc (dcSSc) with

81 Patients who were anti-CarP antibody positive had significantly more disability over

82 renal allografts from hepatitis B virus core antibody-positive (HBcAb(+)), hepatitis B virus surface

83 eradicated or persists at a low level in HCV antibody-positive HCV RNA-negative individuals.

84 between those who were transplanted from HCV antibody-positive (HCV+) vs. HCV antibody-negative donor

85 recombinant immunoblot assay-confirmed, HCV antibody-positive (HCV+), allogeneic blood donors from 1

86 evaluation of antibody-directed therapies in antibody-positive heart failure.

87 HCV-antibody negative recipients of HCV-antibody positive hearts were identified from January 1,

88 The existence of initially antibody-positive HHCs suggests that mild cases of Ebola

89 One H5 antibody-positive household contact, with no history of

90 us mammalian cell systems, reacted with KSHV antibody-positive human sera, resulting in a punctate nu

91 nd no evidence of positive associations with antibody-positive hypothyroidism, hyperthyroidism, AIT,

92 Eight islet cell antibody-positive (ICA+) relatives of IDDM patients were

93 We deemed a patient to be antibody positive if their serum, their CSF, or both tes

94 ected from PWs were considered to be anti-H5 antibody positive if they were positive by both microneu

95 uses/infants born to mothers with anti-Ro/La antibodies (positive IgG).

96 y significant associations between anti-Jo-1 antibody-positive ILD and elevated serum levels of C-rea

97 ease-specific associations between anti-Jo-1 antibody-positive ILD and serum levels of CRP as well as

98 the serum proteins associated with anti-Jo-1 antibody-positive ILD.

99 HCV antibody-positive individuals were 3-fold more likely to

100 econd study determined the proportion of EBO antibody-positive individuals who lived in villages surr

101 The first study determined the proportion of antibody-positive individuals who were self-identified f

102 determined the existence of ILD in anti-Jo-1 antibody-positive individuals whose data were accumulate

103 Among the 90 anti-Jo-1 antibody-positive individuals with sufficient clinical,

104 In this large cohort of anti-Jo-1 antibody-positive individuals, the incidence of ILD appr

105 um thyroiditis in women who are or have been antibody positive is unknown.

106 umatoid factor or anti-citrullinated protein antibody-positive juvenile idiopathic arthritis.

107 id factor- and/or anti-citrullinated protein antibody-positive juvenile idiopathic arthritis.

108 levels were significantly higher in sera of antibody-positive lung cancer patients compared with ant

109 itive, but 18 ocular SNMG patients, 105 AChR antibody positive MG patients, and 108 controls were neg

110 ar-old boy with P-antineutrophil cytoplasmic antibody-positive microscopic polyangiitis, resulting in

111 virus antibody-negative and two rhadinovirus antibody-positive monkeys were used for these experiment

112 No risk was found for children of TPO-antibody-positive mothers (n=308).

113 Of 155 singleton infants born to HCV antibody-positive mothers, 13 (8.4%) were HCV infected.

114 ndex, may differentiate PML risk in anti-JCV antibody-positive MS patients with no prior immunosuppre

115 levels and PML risk was examined in anti-JCV antibody-positive multiple sclerosis (MS) patients from

116 oline receptor [AChR; acetylcholine receptor antibody positive myasthenia gravis (AChR-MG)] by the ra

117 udies confirm three major phenotypes in MuSK antibody positive myasthenia gravis (MMG) patients: indi

118 bodies to muscle specific kinase [MuSK; MuSK antibody positive myasthenia gravis (MuSK-MG)] make up a

119 n how muscle specific tyrosine kinase (MuSK) antibody positive myasthenia gravis results in neuromusc

120 nt of muscle-specific tyrosine kinase (MuSK) antibody positive myasthenia gravis will be reviewed.

121 a diagnosed as having acetylcholine receptor antibody-positive myasthenia gravis and 1998 race/ethnic

122 ibrosis and anti-signal recognition particle antibody-positive myositis.

123 Seven antinuclear antibody-positive, nephritic female (SWR x NZB)F(1) (SNF

124 observational case series of 14 aquaporin-4 antibody positive NMO and NMO spectrum disorder patients

125 to Wingerchuk's 2006 criteria or aquaporin-4 antibody-positive NMO spectrum disorder (NMOSD).

126 six of the 1000 (7.6%) participants were HCV antibody positive; none were confirmed by detection of H

127 reported having sexual partners who were HIV antibody positive (odds ratio = 1.36, 95% confidence int

128 macaques with RRV, whether the animals were antibody positive or negative at the time of virus inocu

129 erences between anti-beta- and/or anti-gamma-antibody positive or negative patients with respect to b

130 d, placebo-controlled trial, 819 antinuclear antibody-positive or anti-double-stranded DNA-positive S

131 surface antibody level >/=10 mIU/mL or core antibody positive, or by documented vaccination.

132 ection in heart transplant recipients of HCV-antibody positive organs is not known.

133 transplant recipients transplanted with HCV antibody-positive organs.

134 ccination at age 6 months and among maternal antibody-positive participants who started vaccination a

135 One antibody positive patient (EMA in isolation) declined du

136 A 55-year-old, JC virus (JCV) antibody-positive patient with multiple sclerosis who di

137 5 leucine-rich, glioma inactivated 1 protein-antibody positive patients (P < 0.0001), who predominant

138 tumour associations in 96 potassium channel antibody positive patients (titres >400 pM).

139 dies to FCS (median initial CD4 count in FCS antibody positive patients = 362.0/microL v median initi

140 42.9% and 63.9% of the DP antibody positive patients had DR/DQ antibodies among th

141 MuSK antibody positive patients represent a unique subset of

142 The 86% frequency of HLA-DQ7 in the antibody positive patients was significant compared with

143 In this study, vimentin antibody positive patients were screened for the presenc

144 ndistinguishable from acetylcholine receptor antibody positive patients, prominent faciopharyngeal we

145 We report 12 aquaporin-4 antibody-positive patients (12% of seropositive Mayo Cli

146 idence of rejection at 1 month was higher in antibody-positive patients (26%) than in antibody-negati

147 We analyzed 36 liver samples from HCV antibody-positive patients (30 from patients with chroni

148 the survival rate was even lower among MICA antibody-positive patients (87.8+/-2.4%) than among MICA

149 In anti-JCV antibody-positive patients (n=21 696), estimated cumulat

150 The 3 retrospectively identified NMDAR antibody-positive patients also had evidence of relapsin

151 g DNA obtained from 318 anti-topoisomerase I antibody-positive patients and 561 healthy controls, all

152 We identified prospectively 52 antibody-positive patients and collated their clinical f

153 HCV RNA was detected in 85% of HCV antibody-positive patients by the whole-blood method com

154 should be made on whether anticoagulation in antibody-positive patients could ameliorate this catastr

155 Antibody-positive patients had lower PANSS positive, PAN

156 Conclusion: Nonviremic HCV antibody-positive patients have a liver biopsy that is u

157 ombocytopenia and thrombosis (HIT), but many antibody-positive patients have normal platelet counts.

158 Moreover, studies of AQP4-antibody-positive patients have revealed that brain lesi

159 For anti-JCV antibody-positive patients in this pooled cohort, cumula

160 ponses in an ELISPOT assay (p = 0.008 versus antibody-positive patients not experiencing ABMR).

161 Whereas antibody-positive patients rarely developed prominent br

162 One hundred antibody-positive patients received a transplant.

163 arly rejection seemed to be more frequent in antibody-positive patients regardless of whether the ant

164 hed controls in each of the 2 antiendomysial antibody-positive patients tested.

165 oral rejection were not more frequent in the antibody-positive patients than in the controls.

166 RT-PCR is a valuable adjunct to serology in antibody-positive patients to distinguish resolved from

167 hich occurred in 79% of the anti-U11/U12 RNP antibody-positive patients versus 37% of the anti-U11/U1

168 04-2005), the prevalence of anti-U11/U12 RNP antibody-positive patients was 15 of 462 (3.2%).

169 The median survival for p53 antibody-positive patients was 51 months (95% CI, 23.5 t

170 When the 379 antibody-positive patients were further tested with beta

171 Anti-topoisomerase I antibody-positive patients were more likely to be never

172 Myelin-oligodendrocyte glycoprotein antibody-positive patients were more likely to have conu

173 No anti-p140 antibody-positive patients were positive for other recog

174 Nineteen (86%) of the antibody-positive patients were viremic (HCV RNA positiv

175 ows further risk stratification for anti-JCV antibody-positive patients who have not previously taken

176 y-two percent of respondents would refer HCV antibody-positive patients with abnormal transaminase le

177 Two anti-glutamic acid decarboxylase antibody-positive patients with SPS had an autologous he

178 Anti-topo I antibody-positive patients with SSc with a rapid STPR ha

179 For anti-JCV antibody-positive patients without previous immunosuppre

180 oach to the management of 2 hypothetical HCV antibody-positive patients, 1 with elevated and the othe

181 Of interest, these antibody-positive patients, although lacking antiphospho

182 (AChR) antibody levels decreased in two AChR antibody-positive patients, and anti-MuSK antibody level

183 An entire subset of antibody-positive patients, anti-N-methyl-d-aspartate re

184 For 60% of the donor-specific antibody-positive patients, antibodies were detected bef

185 ments demonstrated that the IgG from GABARAP antibody-positive patients, but not control IgG, signifi

186 responses were observed against NY-ESO-1 in antibody-positive patients, regardless of their HLA prof

187 However, in alloimmunized lymphocytoxic antibody-positive patients, the immediate increment to U

188 Among antibody-positive patients, the mean +/- SD number of ne

189 returned on 44 N-methyl-d-aspartate receptor antibody-positive patients, we identified a high proport

190 pes for more appropriate treatment for these antibody-positive patients.

191 HLA-DR1 and DR4 haplotypes is reduced among antibody-positive patients.

192 ated PML patients and 2,522 non-PML anti-JCV antibody-positive patients.

193 embranous GN, and antineutrophil cytoplasmic antibody-positive pauci-immune GN.

194 consecutive patients with antimitochondrial antibody-positive PBC who had an incomplete response to

195 cal tests in patients with antimitochondrial antibody-positive PBC who responded incompletely to trea

196 -specific CD4+ T-helper-cell response in HCV antibody-positive persons who lack detectable plasma vir

197 ity of HLA alloantibodies was studied in 128 antibody-positive, potential kidney transplant recipient

198 51 deceased donors) patients (donor-specific antibody positive, PRA>80%) were desensitized using IVIG

199 th anti-Bartonella serum and kittens born to antibody-positive queens with Bartonella henselae to det

200 demonstrated that anti-citrullinated protein antibody positive RA has a specific association with env

201 PN22 with the development of anti-citrulline antibody-positive RA (odds ratio [OR] 1.49; P=.00002), u

202 dy: 86 (48.9%) of 176 patients with anti-CCP antibody-positive RA had at least 1 SE allele, compared

203 ng in the risk of anti-citrullinated protein antibody-positive RA.

204 Antibody-positive reactions to granulocytic Ehrlichia sp

205 of adult renal allograft recipients: (1) HCV antibody positive recipients (R-HCV) (n=32); (2) HCV neg

206 in patients with anti-acetylcholine receptor antibody-positive refractory generalised myasthenia grav

207 Many JC virus antibody-positive relapsing-remitting multiple sclerosis

208 5 of 13 type 1 diabetic subjects and 4 of 6 antibody-positive relatives exhibited greater numbers of

209 determined autoantibodies among cytoplasmic antibody-positive relatives is associated with eligibili

210 D8(+) T-cell response in type 1 subjects and antibody-positive relatives.

211 ed thyroglobulin level without thyroglobulin antibodies, positive results on recent fine-needle aspir

212 bility of G2 and G3 EIAs to confirm anti-HCV antibody-positive results.

213 stological findings were compared between RR antibody positive (RR+) and negative (RR-) patients.

214 Ten glycine receptor antibody positive samples were also identified in a retr

215 The antibody-positive samples represented 76 individuals fro

216 Antibody-positive samples were tested for induction of p

217 n proteins against consecutive antinucleolar antibody-positive sera (HEp-2 cell substrate) collected

218 Antibody-positive sera from 84 mothers of children with

219 ibodies was proved using five representative antibody-positive sera in a complement-dependent cytotox

220 leolus, nucleolar staining by many anti-RNAP antibody-positive sera is not always observed.

221 Antibody-positive sera resulted in downregulation of syn

222 All 18 anti-RNAP I/III antibody-positive sera showed nuclear speckled patterns,

223 Nucleolar staining by anti-RNAP antibody-positive sera was examined by double staining w

224 The anti-OKT3 antibody-positive sera were screened additionally by flo

225 were found in 11 (10%) of 108 antinucleolar antibody-positive sera.

226 r than 1% (2 of 227) of those who were HSV-2 antibody positive seroreverted.

227 Finally, pooled, nonneutralizing SIV-antibody-positive serum, shown in a previous study to pr

228 One hundred seventy-two HCV antibody-positive, serum HCV RNA-negative patients under

229 he effects of rheumatoid factor, antinuclear antibodies, positive skin allergen tests, or IgE concent

230 her hand, such as antineutrophil cytoplasmic antibody-positive small vessel diseases, is largely rest

231 mens tested in MDM culture, 7 (88%) of 8 WNV antibody-positive specimens and 12 (100%) of 12 WNV anti

232 dy-negative specimens and 10 (36%) of 28 WNV antibody-positive specimens were infectious.

233 wed significant association with anti-topo I antibody-positive SSc in white patients (odds ratio [OR]

234 wed significant association with anti-topo I antibody-positive SSc in white patients (OR 2.03, 95% CI

235 Sc, OR 1.63, 95% CI 1.0-2.6; for anti-topo I antibody-positive SSc, OR 2.33, 95% CI 1.5-3.7).

236 association in ACA-positive and anti-topo I antibody-positive SSc.

237 Ten out of thirteen of the antibody-positive subjects agreed to undergo endoscopy.

238 er peptides recognized by type 1 diabetic or antibody-positive subjects included GFAP(143-151), IGRP(

239 The five HCV antibody-positive subjects who were negative by whole-bl

240 associated with ACA-positive and anti-topo I antibody-positive subsets of SSc and represents a risk f

241 h a history of injection drug use and an HCV antibody-positive test result during follow-up.

242 e before left lateral ventricle injection of antibody-positive (test) or healthy (control) immunoglob

243 re were more steroid-resistant rejections in antibody-positive than in antibody-negative patients.

244 diagnostic criteria (i.e., antimitochondrial antibody-positive titer >/=1 in 40, cholestatic liver bl

245 in patients with coronary artery disease and antibodies positive to CPn.

246 effect of each additional short-stored HHV-8 antibody-positive transfusion was 1.79 (95% CI, 1.33-2.4

247 ective studies in which patients known to be antibody positive underwent transplantation.

248 Two probands were antineutrophil cytoplasmic antibody positive vs. 1 of 27 unaffected relatives (P <

249 SSc patients (n = 212) who were anti-topo I antibody positive were divided into 5 subgroups based on

250 c recipients who were pretransplantation CMV antibody positive were longitudinally studied for circul

251 ose who knew that the source subject was HIV antibody positive were more likely to recruit their sour

252 e of prior exposure to HBV (hepatitis B core antibody-positive), whereas 5.8% (95% confidence interva

253 by serosurveillance, as well as a number of antibody positive wild boar on both sides of the border